Pre-Clinical Data Demonstrating Promising Potential of Prexigebersen as Treatment for Solid Tumors in Gynecologic Malignancies Presented at American Association for Cancer Research Annual Meeting

by NASDAQ Market News April 18, 2018

NASDAQ Market News
Click here to email author

Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders

Terveystalo Plc recognizes deferred tax assets with a positive, one-time net result impact of approximately EUR 13 million in the first quarter of 2018

Ads